Slanix Paul Alex
CIK: 0002092283
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PMN
ProMIS Neurosciences Inc.
Director
Discretionary Trading P&L
Holdings
About Alex Slanix Paul
Alex Slanix Paul (SEC CIK 0002092283) files insider reports with the SEC as Director of ProMIS Neurosciences Inc. (PMN).
Signal8 holds 2 ownership filings by Alex Slanix Paul (1 Form 3, 1 Form 4), filed between Oct 24, 2025 and May 22, 2026. Those filings report 2 transactions, the latest on May 20, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Alex Slanix Paul's filings is in TORONTO.
Recent filings by Alex Slanix Paul
- May 20, 2026: Grants or awards of PMN derivative securities (2 lines, Form 4, code A).
Other insiders filing for ProMIS Neurosciences Inc. (PMN)
- Williams Eugene, Director
- Cashman Neil, Chief Scientific Officer
- Rubino Ivana, Chief Commercial Officer
- Kaplan Johanne, Chief Development Officer
- WYMAN WILLIAM W, Director
- Warma Neil K, Chief Executive Officer